InChI | InChI=1S/C16H15N2O6P.2Na/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23;;/h1-10H,11H2,(H,17,20)(H2,21,22,23);;/q;2*+1/p-2 |
Reference | </br>1:Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers. Kaucher KA, Acquisto NM, Rao GG, Kaufman DC, Huntress JD, Forrest A, Haas CE.Pharmacotherapy. 2015 May;35(5):482-8. doi: 10.1002/phar.1589. PMID: 26011141 </br>2:Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers. Inoue Y, Usui N, Hiroki T, Shimizu K, Kobayashi S, Shimasaki S.Eur J Drug Metab Pharmacokinet. 2013 Jun;38(2):139-48. doi: 10.1007/s13318-012-0105-x. Epub 2012 Sep 12. PMID: 22968854 Free PMC Article</br>3:Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers. Tanaka J, Kasai H, Shimizu K, Shimasaki S, Kumagai Y.Eur J Clin Pharmacol. 2013 Mar;69(3):489-97. doi: 10.1007/s00228-012-1373-8. Epub 2012 Aug 24. PMID: 22918614 Free PMC Article</br>4:Fosphenytoin sodium: new drug to replace intravenous phenytoin sodium. Voytko SM, Farrington E.Pediatr Nurs. 1997 Sep-Oct;23(5):503-6. No abstract available. PMID: 9355589 </br>5:Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes. Fischer JH, Cwik MJ, Luer MS, Sibley CB, Deyo KL.Ann Pharmacother. 1997 May;31(5):553-9. PMID: 9161647 </br>6:Safety of fosphenytoin sodium. Fierro LS, Savulich DH, Benezra DA.Am J Health Syst Pharm. 1996 Nov 15;53(22):2707-12. Review. PMID: 8931812
|